Science · Health science · Outbreak research
Andes virus studies strengthen shipboard transmission evidence, leave first source unresolved
New research links the cruise outbreak genetically while showing why location alone cannot settle the first infection.

Two new Andes virus studies strengthen the evidence that people transmitted the virus aboard the M/V Hondius, while leaving the first passengers’ infection source unresolved. South Africa’s National Institute for Communicable Diseases described the findings on 15 November. The research concerns the April–May cruise outbreak.
The outbreak study’s published abstract (opens in a new tab) reports genomes from 10 of 13 identified cases. Read alongside symptom dates and plausible contacts, the genetic evidence strongly supports a connected cluster consistent with one or very few animal-to-human introductions before boarding, followed by transmission between people aboard.
The authors do not interpret the cluster as evidence that an unusual new viral strain emerged. The distinction is between where transmission occurred and whether the virus had acquired a new character.
Investigators at Geneva University Hospitals (opens in a new tab) describe a particularly useful late case: symptoms began on 31 May after prolonged close contact with another infected person. That sequence supports exposure later in the voyage rather than treating every illness as the result of a shared encounter before departure.
The second study’s abstract on the virus’s genetic history (opens in a new tab) places related cases from 2018–2025 in a defined area of northern Patagonia. Reconstructing the first cruise patients’ journey identified geographically plausible exposures, but their timing did not fit the expected incubation period. The authors therefore leave the initial infection source unresolved.
A lineage’s presence in a region can guide an investigation without identifying the place where a particular traveller was infected. The study calls for broader surveillance in the endemic area to help close that evidence gap.
The NICD account (opens in a new tab) describes South African laboratory work within an international investigation that shared raw sequencing data and checked results across teams. Those checks matter when very small genetic differences are used to reconstruct relationships between cases.
A separate US public-health investigation published on 5 November (opens in a new tab) followed 88 US-resident contacts across 27 jurisdictions. All completed 42 days of monitoring, with no secondary infection identified in that cohort. That result describes the monitored group; it does not overturn evidence of transmission among cases aboard the ship.
Together, the reports point to two continuing scientific tasks: improve the historical sampling needed to trace the virus’s origins, and preserve detailed contact and symptom histories to interpret genetic links. More sequences are most useful when investigators can connect them to when and where exposure was possible.
Sources, evidence and corrections
- NICD account of Andes virus studies (opens in a new tab) · 15 November 2026
- Science cruise-outbreak abstract (opens in a new tab) · 12 November 2026
- Geneva investigators on late case (opens in a new tab) · 13 November 2026
- Science Patagonia-lineage abstract (opens in a new tab) · 12 November 2026
- CDC US contact investigation (opens in a new tab) · 5 November 2026
